Jyong Biotech Ltd. (MENS) Operating income 2023–2025
Jyong Biotech Ltd. (MENS) annual operating income history from SEC filings — each fiscal year as reported.
-$2.6MFY2025 · since FY2023: -$2.8M → -$2.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.6M | -26.8% |
| FY2024 | -$2.1M | +26.5% |
| FY2023 | -$2.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MENS financial trends
MENS RevenueMENS Net incomeMENS Net marginMENS Gross profitMENS Gross marginMENS Operating marginMENS Operating cash flowMENS Free cash flowMENS Capital expendituresMENS Return on equityMENS Stock buybacksMENS Dividends paidMENS Total assetsMENS Total liabilitiesMENS Shareholders’ equityMENS overview →